Skip to main content
OpenTrials
Completed

NCT Number: NCT03891407

Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men

The purpose of this study is to recruit and train men to promote HIV self-testing to their network members in their camps and examine the efficacy of a peer-led HIV self-testing intervention on the uptake of HIV testing among men.

Completed

Looking for future studies?

Notify Me

Key information

About this study

The research is the first evaluation of an unsupervised HIV self-testing strategy in Tanzania focusing on networks of heterosexual men. The reasons for focusing on heterosexual men is because heterosexual contact is the primary mode of HIV transmission in Tanzania and data from our previous trial indicate that 97% of the male camp members are heterosexual. Moreover it will be the first intervention to engage male peer leaders to promote HIV self-testing in their social networks in Tanzania. We will build on previous work our research team has conducted to identify 'camps' or local venues where young men socialize with elected leaders and members pay membership dues. Our previous intervention has proven successful to recruit and train leaders from camps to serve as community health leaders in their respective camps, with the goal of changing social norms related to HIV and gender-based violence. A novel approach to the proposed research is that we will leverage the work we have conducted within camps with social networks of men to test the acceptability and feasibility of oral fluid-based HIV self-testing and confirmatory blood-based HIV testing within existing networks of men that we know we can access through stable social venues. We will recruit male camp leaders to train them about HIV self-testing and instruct them to return to their camps and engage their male peers by informing them about HIV self-testing for prior to our research team offering participants the opportunity to self-test.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participant is at least 18 years old
  • Has been member of the camp for at least 3 months
  • Visits camp at least once a week
  • Intends to live in Dar es Salaam for next 6 months
  • Has not had suicidal thoughts in the past
  • Willing to give contact information of self and relative or friend

Exclusion criteria

  • Does not meet all inclusion criteria
  • Unable to participate due to psychological disturbance, cognitive impairment or threatening behavior

Treatment and study plan

Self-Testing Education and Promotion

Diagnostic Test

Camp members will receive the Self-Testing Education and Promotion (STEP locally referred to as Mate Yako Afya Yako) intervention and will receive HIV-counseling and oral HIV self-testing kits.

Primary outcomes

  1. Number of HIV self-testing kits distributed in the past 3 Months

    Time frame: 3 months

    Camp members' use of the HIV self-testing kits will be evaluated at 3 months

Secondary outcomes

  1. Number of camp members who self-report HIV self-testing in the past 3 months

    Time frame: 3 months

    Camp members will self-report HIV self-testing at 3 Months

Sponsors and collaborators

Lead sponsor

University of South Carolina

Other

Registry information

Official study title

Acceptability and Feasibility of Unsupervised HIV Self-Testing Among Networks of Men:Tanzania STEP (Self-Testing Education and Promotion) Project

Acronym: STEP

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Mar 27, 2019
Registry last updated
Nov 25, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.